Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

Radiology Partners

Radiology Partners Raises $720M in Growth Equity

El Segundo, CAFebruary 22, 20242 min read
Employees
3600+

Radiology Partners Raises $720M in Growth Equity


Radiology Partners has successfully raised $720M in a Growth Equity at a $2B valuation led by Existing and new investors.


Company Overview


Radiology Partners is a HealthTech company headquartered in El Segundo, CA, founded in 2012 with 3600+ employees.


Nation's largest radiology practice providing diagnostic imaging services


Fundraising Details


  • Amount Raised: $720M
  • Round Type: Growth Equity
  • Valuation: $2B
  • Date: 2024-02-22
  • Investors: Existing and new investors

About Radiology Partners


Nation's largest radiology practice providing diagnostic imaging services The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: El Segundo, CA
  • Founded: 2012
  • Team Size: 3600+
  • Industry: HealthTech

What This Means


This funding round demonstrates strong investor confidence in Radiology Partners's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Radiology Partners's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $2B valuation marks an important milestone for Radiology Partners, positioning the company among notable players in the HealthTech industry.


Looking Ahead


With this new capital, Radiology Partners is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-02-22. For more information about Radiology Partners, visit their headquarters at El Segundo, CA.

Company Info

Headquarters
El Segundo, CA
Founded
2012
Team Size
3600+

Topics

Fundraising(2912)HealthTech(503)Growth EquityRadiology Partners

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min readβ€’$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free